Digital repository of Slovenian research organisations

Search the repository
A+ | A- | Help | SLO | ENG

Query: search in
search in
search in
search in

Options:
  Reset


Query: "keywords" (guidelines) .

1 - 10 / 22
First pagePrevious page123Next pageLast page
1.
2.
Screening of lipids and kidney function in children and adolescents with type 1 diabetes : does age matter?
Eulalia Catamo, Antonietta Robino, Klemen Dovč, Davide Tinti, Gianluca Tamaro, Riccardo Bonfanti, Roberto Franceschini, Ivana Rabbone, Tadej Battelino, Gianluca Tornese, 2023, original scientific article

Abstract: Introduction: The purpose of this study was to evaluate lipid profile and kidney function in children and adolescents with Type 1 Diabetes. Methods: This was a retrospective study including 324 children and adolescents with Type 1 Diabetes (48% females, mean age 13.1 ± 3.2 years). For all participants, demographic and clinical information were collected. The prevalence of dyslipidemia and kidney function markers were analyzed according to age. Multivariate linear regression analyses were performed to test the association of lipids or markers of renal function with demographic and clinical information (sex, age, disease duration, BMI SDS, HbA1c). Results: In our study the rate of dyslipidemia reached 32% in children <11 years and 18.5% in those ≥11 years. Children <11 years presented significantly higher triglyceride values. While the albumin-to-creatinine ratio was normal in all individuals, 17% had mildly reduced estimated glomerular filtration rate. Median of HbA1c was the most important determinant of lipids and kidney function, being associated with Total Cholesterol (p-value<0.001); LDL Cholesterol (pvalue= 0.009), HDL Cholesterol (p-value=0.045) and eGFR (p-value=0.001). Conclusion: Dyslipidemia could be present both in children and adolescents, suggesting that screening for markers of diabetic complications should be performed regardless of age, pubertal stage, or disease duration, to optimize glycemia and medical nutrition therapy and/or to start a specific medical treatment.
Keywords: type 1 diabetes, diabetes care, lipids profile, kidney function, age, guidelines
Published in DiRROS: 01.09.2026; Views: 139; Downloads: 82
.pdf Full text (407,00 KB)
This document has many files! More...

3.
Quantitative comparison of food-based dietary guidelines : alignment with the Slovenian nutrition guidelines 2025 and Slovenian intake
Samo Kreft, Eva Tavčar, Anne Carolin Schäfer, Nataša Sivec, Zlatko Fras, Boštjan Jakše, Nataša Fidler Mis, 2026, review article

Abstract: Purpose: Food-based dietary guidelines (FBDGs) are a key instrument for translating nutrition science into public health advice, yet direct comparison across guidelines is hindered by differences in food grouping, units, and formulation of recommendations. Slovenia has recently developed and scientifically completed the Slovenian Nutrition Guidelines 2025 (SNG2025), its updated FBDGs, which have been submitted for governmental adoption but are not yet officially adopted. The SNG2025 extend conventional FBDGs into a quantitative, plant-forward framework that integrates health and environmental sustainability. However, their quantitative position relative to contemporary international guidelines and nationally representative intake data has not yet been systematically evaluated. Methods: We compared 13 national FBDGs (Denmark, Finland, Sweden, Norway, Germany, Austria, Spain, France, Canada, United States, China, United Kingdom and Australia) and two international frameworks (Nordic Nutrition Recommendations and EAT–Lancet) with the SNG2025. Recommendations were extracted for major food groups and mathematically converted (standardised) to a common unit (g/day) using predefined conversion factors and explicitly stated assumptions. Results: The SNG2025 are largely consistent with international practice. Strong convergence was observed for fruits and vegetables, while recommendations for legumes, nuts, and whole grains closely aligned with EAT–Lancet targets and those from Spain and Austria. Slovenian upper limits for meat, dairy and eggs were comparable to those in several European and international guidelines; notably, some FBDGs suggest more stringent reductions than the SNG2025. Several guidelines allow fortified plant-based alternatives to fully replace animal-based dairy. Greater variability was observed for fish and seafood, reflecting regional dietary traditions. Significant heterogeneity in the formulation of recommendations (e.g., portion-based vs. weight-based) was identified. Conclusions: The SNG2025 are well aligned with contemporary international and national recommendations and align with widely accepted quantitative ranges for all major food groups. Differences between guidelines reflect cultural framing and quantification rather than conflicting nutritional principles. The SNG2025 demonstrate that contemporary dietary guidelines can integrate quantitative guidance, a plant-forward approach, and sustainability considerations while remaining aligned with international evidence. These findings support the use of SNG2025 as a reference framework for the development and evaluation of future dietary guidelines in comparable settings.
Keywords: food-based dietary guidelines ·, dietary recommendations, plant-forward diet ·, sustainable diet, international comparison, food groups, EAT–lancet, nordic nutrition recommendations
Published in DiRROS: 24.07.2026; Views: 275; Downloads: 192
.pdf Full text (1,41 MB)
This document has many files! More...

4.
5.
ESTES recommendations for the treatment of polytrauma-a European consensus based on the German S3 guidelines for the treatment of patients with severe/multiple injuries
Cristina Rey Valcarcel, Dan Bieler, Gary A. Bass, Christine Gaarder, Frank Hildebrand, 2025, original scientific article

Abstract: Introduction: Considerable heterogeneity exists in the configuration and implementation maturity of trauma systems across European healthcare settings, and the opportunities for guideline-informed high-quality care varies considerably. Therefore, the European Society of Trauma and Emergency Surgery (ESTES), with its constituent national societies, has developed comprehensive consensus recommendations for care-context appropriate treatment of polytrauma patients in Europe, from the pre-hospital setting to the first surgical phase. Methods: Adhering to the RAND/UCLA Appropriateness Method (RAM), ESTES conducted a three-round modified Delphi consensus. National society expert delegates assessed Grade of Recommendation (GoR) A and Good Clinical Practice Points (GPP) elements of the German Society of Trauma Surgery (DGU) “S3 guidelines for polytrauma/severe injury management” for appropriateness and implementability within their respective healthcare systems. Results: In the first consensus round, 82 GoR A and 57 GPP recommendations were analysed. Of these, seven GPP were rephrased for clarity and four were removed due to redundancy or conflicting content. Consequently, 135 recommendations (82 GoR A and 53 GPP) remained, with 128 (77 GoR A and 51 GPP) deemed appropriate and necessary, and seven as uncertain due to expert disagreement. Conclusion: These ESTES recommendations constitute the first cohesive Europe-wide framework for managing the polytrauma patient from the prehospital setting to the end of the first surgical phase. They serve as a foundational tool for the development of national guidelines, particularly in regions with evolving trauma systems, and promote alignment towards a uniform standard-of-care across Europe.
Keywords: polytrauma, injury, guidelines, recommendations, consensus
Published in DiRROS: 20.05.2026; Views: 486; Downloads: 247
.pdf Full text (797,53 KB)
This document has many files! More...

6.
Structured stillbirth management in Slovenia : outcomes and comparison with international guidelines
Maja Dolanc Merc, Tanja Premru-Sršen, 2026, other scientific articles

Abstract: Background: Stillbirth remains a major public health issue with long-lasting psychological impacts. Despite advancements in prenatal diagnostics, many stillbirths remain unexplained. Slovenia has implemented a structured, centralized algorithm for stillbirth investigation and care. Content: This mini-review analyzes a decade of clinical data (2013-2023) from the Department of Perinatology at University Medical Centre Ljubljana (UMC Ljubljana), assessing the outcomes of Slovenia's stillbirth management algorithm. The Slovenian approach is also compared with international guidelines from ACOG, RCOG, CNGOF, PSANZ, SOGC, and FOGSI. Slovenia reports one of the lowest stillbirth rates in Europe - 2 per 1,000 births at ≥24 weeks and 1.4 per 1,000 at ≥28 weeks. At UMC Ljubljana, fetal death rates remained stable between 0.4 % and 0.6 %. The structured algorithm includes maternal history, laboratory testing, placental and fetal pathology, and genetic evaluation. Active induction is preferred over expectant management, and routine TORCH screening and centralized committee oversight are emphasized. Summary: Slovenia's structured, algorithm-based system has led to notably low stillbirth rates, supported by uniform clinical care and systematic investigations. Although Slovenia's experience is encouraging, these results derive from a single-center national registry without comparative cohort analysis, limiting attribution of outcomes to specific elements of the algorithm. Outlook: Future progress will involve the expansion of WES access and full ICD-PM implementation by 2027, enhancing data comparability and facilitating broader international research.
Keywords: Slovenia, international guidelines, investigation algorithm, perinatal mortality, stillbirth, structured care
Published in DiRROS: 08.05.2026; Views: 351; Downloads: 295
.pdf Full text (1,22 MB)
This document has many files! More...

7.
European S2k guidelines for hidradenitis suppurativa/acne inversa part 2 : treatment
C. C. Zouboulis, Falk G. Bechara, F. Benhadou, V. Bettoli, Z. Bukvić Mokos, V. Del Marmol, Mateja Dolenc-Voljč, E. J. Giamarellos-Bourboulis, Ø. Grimstad, Philippe Guillem, 2025, review article

Abstract: Introduction: This second part of the S2k guidelines is an update of the 2015 S1 European guidelines. Objective: These guidelines aim to provide an accepted decision aid for the selection, implementation and assessment of appropriate and sufficient therapy for patients with hidradenitis suppurativa/acne inversa (HS). Methods: The chapters have been selected after a Delphi procedure among the experts/authors. Certain passages have been adopted without changes from the previous version. Potential treatment complications are not included, being beyond the scope of these guidelines. Results: Since the S1 guidelines publication, validation of new therapeutic approaches has almost completely overhauled the knowledge in the field of HS treatment. Inflammatory nodules/abscesses/draining tunnels are the primary lesions, which enable the classification of the disease severity by new validated tools. In relation to the degree of detectable inflammation, HS is classified into the inflammatory and the predominantly non-inflammatory forms. While the intensity of the inflammatory form can be subdivided by the IHS4 classification in mild, moderate and severe HS and is treated by medication accordingly, the decision on surgical treatment of the predominantly non-inflammatory form is based on the Hurley stage of the affected localization. The effectiveness of oral tetracyclines as an alternative to the oral combination of clindamycin/rifampicin should be noted. The duration of systemic antibiotic therapy can be shortened by a 5-day intravenous clindamycin treatment. Adalimumab, secukinumab and bimekizumab subcutaneous administration has been approved by the EMA for the treatment of moderate-to-severe HS. Various surgical procedures are available for the predominantly non-inflammatory form of the disease. The combination of a medical therapy to reduce inflammation with a surgical procedure to remove irreversible tissue damage is currently considered a holistic therapeutic approach. Conclusions: Suitable therapeutic options while considering HS severity in the therapeutic algorithm according to standardized criteria are aimed at ensuring a proper therapy.
Keywords: hidradenitis suppurativa/acne inversa, guidelines, European S2k gudelines, tretament
Published in DiRROS: 22.04.2026; Views: 330; Downloads: 273
.pdf Full text (3,44 MB)
This document has many files! More...

8.
Three-tier plate, triple win : health, sustainability, and equity in the Slovenian nutrition guidelines 2025
Nataša Fidler Mis, Boštjan Jakše, Samo Kreft, Ana Vovk, Zlatko Fras, 2026, original scientific article

Abstract: The prevalence of diet-related noncommunicable diseases (NCDs; e.g., obesity, type 2 diabetes, cardiovascular disease, and certain cancers) is increasing globally, while food systems are also driving climate change and biodiversity loss. Transitioning to predominantly plant-based (“plant-forward”) dietary patterns can improve health and lower environmental impacts. We present the Slovenian Nutrition Guidelines 2025 (SNG2025)—their methodology, development, and core recommendations. Developed as adult food-based dietary guidelines, the SNG2025 are evidence-informed, drawing on the scientific literature, national nutritional data, and expert consensus. We set quantitative daily intake targets by integrating evidence on primary NCD outcomes with environmental metrics (greenhouse gas emissions, land use, and water use), which led to upper limits for animal-based foods. The recommended plant-forward dietary pattern, aligned with the EAT–Lancet planetary health diet, emphasises vegetables, fruits, legumes, whole grains, nuts, seeds, and unsaturated oils; allows low-to-moderate amounts of seafood, poultry, dairy, and eggs; and keeps red and processed meat, free sugars, refined grains, saturated fat, salt, ultra-processed foods (UPFs), and alcohol to a minimum. For the first time, we operationalise health, environmental sustainability, and equity (cultural diversity and accessibility) through a three-tier, plant-forward food plate model (Mediterranean, vegetarian [lacto-ovo], and whole food, plant-based [vegan]). The SNG2025 aim to reduce the risk of NCDs, lower the dietary environmental footprint, and improve fair access to healthy food. They signal a shift from disease management to a prevention-oriented, systems approach that aligns health and ecological goals. With robust implementation, supportive policies, and multisector collaboration, the SNG2025 can strengthen population health, foster more resilient food systems, and advance equity and long-term sustainability.
Keywords: healthy diets, sustainable diets, dietery guidelines, healthy food, vegetarian diet, Slovenia
Published in DiRROS: 07.04.2026; Views: 401; Downloads: 336
.pdf Full text (1,05 MB)
This document has many files! More...

9.
Suboptimal management of hypercholesterolemia in countries with high or very high cardiovascular risk : findings from the international DISCOVERY study
Mišo Šabovič, Hristo Pejkov, Alexandru Caraus, Ivan Gruev, Vlad Damian Vintilă, Zoltán Csanádi, Sodgerel Batjargal, Tamara Kovačević -Preradović, Zumreta Kusljugić, Draško Kuprešak, 2025, original scientific article

Abstract: Introduction: The 2019 ESC/EAS guidelines introduced stricter low-density lipoprotein cholesterol (LDL-C) targets, particularly for patients at high and very high cardiovascular (CV) risk. However, data on the implementation of these targets in real-world clinical practice—especially in countries with high/very high CV risk—remain limited. The DISCOVERY study aimed to assess LDL-C management, lipid-lowering therapy (LLT) use, and guideline adherence across multiple countries in Central and Eastern Europe and Central Asia. Methods: This prospective, observational, multicenter study enrolled adult patients with hypercholesterolemia (HCL) from 10 countries grouped into three regions. Data was collected at baseline and after 12 weeks of follow-up. LLT patterns, LDL-C levels, target attainment (both investigator-defined and 2019 ESC/EAS-recommended), and physician adherence to guidelines were analyzed. Results: A total of 6,447 patients were included; 53.2% were female, and the mean age was 60.5 ± 11.9 years. Most patients (66%) were in secondary prevention. At baseline, 36.8% had been treated with LLT. After the first visit, treatment was changed in 78% of patients, but only 42.4% received highintensity statins and 9.3% received statin-ezetimibe combinations at followup. LDL-C target achievement was poor: only 5.6% of patients met the guideline-recommended LDL-C goals, compared to 45.5% who met physician-defined targets. Among patients with ASCVD, only 3.3% achieved guideline LDL-C targets. The most significant gap was observed between guideline recommendations and physician-set LDL-C goals. No significant difference in LDL-C target attainment was observed between specialists and general practitioners. Discussion: The DISCOVERY study reveals suboptimal LDL-C control and low adherence to the 2019 ESC/EAS guidelines in routine practice across countries with high/very high CV risk. These findings highlight the urgent need for strategies to improve physician awareness, promote intensive LLT use, and close the gap between guidelines and clinical practice. A paradigm shift toward proactive LDL-C management is essential to reduce residual CV risk in these populations.
Keywords: LDL-C, hypercholesterolemia, lipid-lowering therapy, ESC/EAS guidelines, cardiovascular risk, real-world evidence, statins, ezetimibe
Published in DiRROS: 31.03.2026; Views: 492; Downloads: 257
.pdf Full text (921,50 KB)
This document has many files! More...

10.
Prioritizing topics for a clinical practice guideline on SATB2-associated syndrome : methodological rigor versus clinical usability
Charlotte M.W. Gaasterland, Mirthe J. Klein Haneveld, Barber M. Tinselboer, Yuri A. Zarate, Damjan Osredkar, Agnies M. van Eeghen, Erika Stariha, 2026, original scientific article

Abstract: Objective SATB2-associated syndrome (SAS) is a rare genetic condition characterized by developmental delay and typical features. Currently, an evidence-based Clinical Practice Guideline (CPG) is being developed by European Reference Network ITHACA in close collaboration with the patient community. To ensure that the guideline addresses the most pressing concerns of affected individuals, families and clinicians, while remaining feasible to produce, a prioritization process was carried out. Study design and setting The prioritization process aimed to minimize the relevant clinical questions to a maximum of 12, based on criteria that were defined beforehand and based on input from a large patient community. The prioritization process included a SAS community-wide survey that collected all patient-relevant topics, a prioritization round using a tool that helps to calculate the items that were most voted on, and a final consensus round with the guideline core group. Results In the first round, a total of 376 topics was collected based on input from over 20 families. These were combined and refined into 48 clinical topics. A total of 269 valid responders filled in their prioritization on these topics in an online survey. Of these respondents, 234 identified as representative/family/carer, 30 identified as clinician, and 5 individuals identified as both. Rather than prioritizing a subset of 12 topics, that each would be answered with a systematic review, the core group decided on a final set of 22 questions and only one systematic review. Conclusion Despite using a rigorous, community-driven process with input from many parents, carers, and global clinical experts, the guideline core group could not agree on a final set of 12 clinical topics. The group concluded that completeness and clinical usability of the guideline should take precedence over adhering to 12 prioritized clinical topics that could each be answered with a systematic search in the literature. We concluded that completeness and usability, versus methodological rigor, are competing interests in CPG development. This methodological issue is a pressing matter in the field of rare disease CPG development, and possibly also beyond the context of rare diseases, for which no clear solution currently exists.
Keywords: clinical practice guidelines, rare diseases, prioritization, guideline methodology, systematic reviews, European reference network
Published in DiRROS: 19.03.2026; Views: 535; Downloads: 359
.pdf Full text (707,73 KB)
This document has many files! More...

Search done in 5.02 sec.
Back to top